Status:

COMPLETED

The Impact of a Pluridisciplinary Education Program on Venous Leg Ulcer Size Reduction

Lead Sponsor:

School of Health Sciences Geneva

Conditions:

Patient Empowerment

Venous Leg Ulcer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Background and rationale: Venous leg ulcers (VLU) are slow healing wounds with a recurrence rate of 70% and a 60% risk of becoming chronic. The estimated VLU prevalence in the general population is 3%...

Detailed Description

Background and rationale: Venous leg ulcers (VLU) are slow healing wounds with a recurrence rate of 70% and a 60% risk of becoming chronic. Signs and symptoms such as pain or exudate are not only a bu...

Eligibility Criteria

Inclusion

  • 18 years or older,
  • an existing diagnosed open VLU,
  • ulcer surface \>5 cm2 and \> 15 cm2,
  • proficiency in the French language

Exclusion

  • Valid informed consent is not or cannot be given

Key Trial Info

Start Date :

February 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 31 2024

Estimated Enrollment :

87 Patients enrolled

Trial Details

Trial ID

NCT04019340

Start Date

February 1 2020

End Date

January 31 2024

Last Update

July 29 2024

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Cité Génération Maison de santé

Onex, Canton of Geneva, Switzerland, 1213

2

Centre hospitalier universitaire vaudois

Lausanne, Canton of Vaud, Switzerland, 1005

3

University Hospital Geneva

Geneva, Switzerland, 1206